Education
About Us
Working with TipRanks
Follow Us
Surgery Partners Inc (SGRY)
NASDAQ:SGRY
Earnings Data
Report Date
Aug 05, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.18Last Year’s EPS
0.21Same Quarter Last Year
Moderate Buy
Based on 11 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 12, 2025
|% Change Since: 8.03%
|Next Earnings Date:Aug 05, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue and case growth, successful physician recruitment, and a robust M&A pipeline, indicating a positive business trajectory. However, slight margin pressure, increased interest expenses, and first-quarter cash flow challenges were noted as concerns.Company Guidance
In the first quarter of 2025, Surgery Partners reported net revenue of $776 million and adjusted EBITDA of $103.9 million, marking growth of 8% and nearly 7%, respectively, compared to the previous year. The company's growth was driven by a 6.5% increase in surgical case volume, although offset by a 1% decline in rates, primarily due to growth in lower acuity specialties. Same-facility revenue growth was over 5%, with expectations for full-year growth to reach or exceed 6%. Surgery Partners completed over 160,000 surgical cases, with a notable 22% growth in total joint procedures within orthopedics. The company also focused on expanding its capabilities, adding 150 new physicians and investing in 68 surgical robots. For M&A, $55 million was deployed to add five surgical facilities, and 10 de novo facilities are under construction. The company's liquidity stood at over $615 million, supporting its 2025 guidance of $3.3 to $3.45 billion in revenue and $555 to $565 million in adjusted EBITDA.Strong Revenue and EBITDA Growth
Surgery Partners reported first quarter net revenue of $776 million and adjusted EBITDA of $103.9 million, both in line with expectations. Adjusted EBITDA grew nearly 7% and net revenue grew 8% compared to the prior year's first quarter.
Significant Surgical Case Growth
The company performed over 160,000 surgical cases in the first quarter, a 4.5% increase from 2024. Notably, orthopedic cases grew 3.4%, with total joint procedures increasing by 22%.
Successful Physician Recruitment
Nearly 150 new physicians were added in the first quarter, expected to bring higher overall acuity cases compared to prior cohorts. Revenue per physician from this cohort is up 14% compared to 2024.
Robust M&A Activity
To date in 2025, Surgery Partners deployed $55 million and added 5 surgical facilities at an effective multiple under 8x adjusted EBITDA. The M&A pipeline remains robust.
De Novo Facility Expansion
The company opened 8 de novo facilities in 2024 and currently has 10 under construction, focusing on higher acuity specialties like orthopedics.
---
SGRY Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
SGRY Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 12, 2025 | $22.16 | $23.26 | +4.96% |
Mar 03, 2025 | $24.08 | $24.00 | -0.33% |
Nov 12, 2024 | $31.43 | $29.57 | -5.92% |
Aug 06, 2024 | $28.72 | $29.64 | +3.20% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Surgery Partners Inc (SGRY) report earnings?
Surgery Partners Inc (SGRY) is schdueled to report earning on Aug 05, 2025, TBA Not Confirmed.
What is Surgery Partners Inc (SGRY) earnings time?
Surgery Partners Inc (SGRY) earnings time is at Aug 05, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SGRY EPS forecast?
SGRY EPS forecast for the fiscal quarter 2025 (Q2) is 0.18.
---